Importância do diagnóstico da síndrome metabólica na determinação do risco cardiovascular em pacientes hipertensos

Show simple item record

dc.contributor.advisor Zanella, Maria Teresa [UNIFESP]
dc.contributor.author Hirota, Andrea Harumi [UNIFESP]
dc.date.accessioned 2015-12-06T23:47:38Z
dc.date.available 2015-12-06T23:47:38Z
dc.date.issued 2008
dc.identifier.citation HIROTA, Andrea Harumi. Importância do diagnóstico da síndrome metabólica na determinação do risco cardiovascular em pacientes hipertensos. 2008. 33 p. Dissertação (Mestrado em Ciências) - Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, 2008.
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/24143
dc.description.abstract We evaluated the significance of a diagnosis of metabolic syndrome (MetS), as defined by the National Cholesterol Education Program (NCEP) and by the International Diabetes Federation (IDF), in the evaluation of cardiovascular risk in hypertensive patients. The patients were evaluated to identify MetS and any history of cardiovascular disease (CVD). This was a cross-sectional study involving 638 patients, of which 202 (31.7%) had diabetes. The prevalence of MetS was 54.7% when the IDF criteria were used, compared with 45.5% when the NCEP criteria were used (p < 0.05). Using either set of criteria, MetS was associated with type 2 diabetes mellitus (T2DM) (NCEP,OR: 6.8; 95% CI: 4.7-10 and IDF, OR: 8.4; 95% CI: 5.4-13; p < 0.05 for both). We found that, regardless of the diagnostic criteria used, MetS correlated significantly with the risk and history of CVD (NCEP, OR: 2.04; 95% CI: 1.2-3.4; p < 0.05; and IDF, OR: 2.68; 95% CI: 1.5-4.8; p < 0.05), partially caused by the inclusion of patients with diabetes in the sample. In patients without diabetes, MetS diagnosed using the IDF criteria alone was associated with a history of CVD (OR: 2.4; 95% CI: 1.1-5.2; p = 0.029 vs. NCEP criteria, OR: 1.99; 95% CI: 0.9-4.3, p = NS). In patients with T2DM, MetS was not associated with CVD, regardless of the criteria used. We conclude that, among individuals without diabetes, an IDF criteria-based diagnosis of MetS is useful in identifying those at greater risk for cardiovascular disease. Among patients with diabetes, a diagnosis of MetS, regardless of the criteria used, is of little utility in assessing cardiovascular risk. However, a diagnosis of MetS, using either set of criteria, is useful for identifying individuals more likely to develop T2DM.
dc.format.extent 33 p.
dc.language.iso por
dc.publisher Universidade Federal de São Paulo (UNIFESP)
dc.rights Acesso aberto
dc.subject Síndrome X Metabólica pt
dc.subject Doenças Cardiovasculares pt
dc.subject Fatores de Risco pt
dc.subject Metabolic Syndrome
dc.subject Cardiovascular Disease
dc.subject Cardiovascular Risk Factors
dc.title Importância do diagnóstico da síndrome metabólica na determinação do risco cardiovascular em pacientes hipertensos pt
dc.title.alternative Importance of the diagnosis of metabolic syndrome in determing cardiovascular risk en
dc.type Dissertação de mestrado
dc.contributor.institution Universidade Federal de São Paulo (UNIFESP)
dc.identifier.file epm-9012615342343.pdf
dc.identifier.file Publica-24143.pdf
dc.description.source BV UNIFESP: Teses e dissertações
unifesp.campus Escola Paulista de Medicina (EPM) pt
unifesp.graduateProgram Medicina (Endocrinologia clínica) - EPM



File

Name: Publica-24143.pdf
Size: 428.7Kb
Format: PDF
Description:
Open file

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account